| Date Filed | Type | Description |
| 05/19/2023 |
4
| Loewy Caroline M (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 3,750 restricted stock units
@ $0 |
|
| 01/27/2023 |
4
| Loewy Caroline M (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $7.8, valued at
$195k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Loewy Caroline M (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 17,500 options to buy
@ $0.8419, valued at
$14.7k
Granted 3,750 restricted stock units
@ $0 |
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Loewy Caroline M (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 67,000 options to buy
@ $2.94, valued at
$197k
|
|
| 01/20/2022 |
4
| Loewy Caroline M (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.34, valued at
$67k
|
|
| 10/12/2021 |
4
| Loewy Caroline M (Director) has filed a Form 4 on PHOENIX BIOTECH ACQUISITION CORP.|
Txns:
| Acquired 17,500 options to buy
@ $0 |
|
| 10/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2021 |
4
| Loewy Caroline M (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 14,000 options to buy
@ $3.53, valued at
$49.4k
|
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Loewy Caroline M (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $5.78, valued at
$185k
|
|
| 01/14/2021 |
4
| Loewy Caroline M (Director) has filed a Form 4 on Locust Walk Acquisition Corp.|
Txns:
| Disposed of 17,500 options to buy
@ $0 |
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2020 |
4
| Loewy Caroline M (Director) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Granted 20,000 options to buy
@ $22.82, valued at
$456.4k
|
|
| 09/23/2020 |
3
| Loewy Caroline M (Director) has filed a Form 3 on ZOGENIX, INC. |
| 06/05/2020 |
4
| Loewy Caroline M (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 16,000 options to buy
@ $0 |
|
| 05/19/2020 |
4
| Loewy Caroline M (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 49,245 options to buy
@ $4.05, valued at
$199.4k
|
|
| 03/13/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Loewy Caroline M (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 65,000 options to buy
@ $6.91, valued at
$449.2k
|
|
| 05/13/2019 |
4
| Loewy Caroline M (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 9,167 options to buy
@ $13.23, valued at
$121.3k
|
|
| 03/01/2019 |
4
| Loewy Caroline M (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 8,900 options to buy
@ $3.15, valued at
$28k
|
|
| 01/31/2019 |
4
| Loewy Caroline M (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 27,705 options to buy
@ $8.43, valued at
$233.6k
|
|
| 01/03/2019 |
4
| Loewy Caroline M (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.91, valued at
$76.4k
|
|
| 12/21/2018 |
3
| Loewy Caroline M (Director) has filed a Form 3 on Aptose Biosciences Inc. |
| 10/17/2018 |
3
| Loewy Caroline M (Director) has filed a Form 3 on PhaseBio Pharmaceuticals Inc |
| 01/26/2018 |
4
| Loewy Caroline M (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $11.69, valued at
$187k
|
|
| 09/26/2017 |
4
| Loewy Caroline M (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $7.47, valued at
$56k
|
|
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/08/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 12/02/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |